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DOI: 10.1039/c2lc21129gThe development of a method for high-throughput, automated pro-
teomic screening could impact areas ranging from fundamental
molecular interactions to the discovery of novel disease markers and
therapeutic targets. Surface display techniques allow for efficient
handling of large molecular libraries in small volumes. In particular,
phage display has emerged as a powerful technology for selecting
peptides and proteins with enhanced, target-specific binding affini-
ties. Yet, the process becomes cumbersome and time-consuming
when multiple targets are involved. Here we demonstrate for the first
time a microfluidic chip capable of identifying high affinity phage-
displayed peptides for multiple targets in just a single round and
without the need for bacterial infection. The chip is shown to be able
to yield well-established control consensus sequences while simul-
taneously identifying new sequences for clinically important targets.
Indeed, the confined parameters of the device allow not only for
highly controlled assay conditions but also introduce a significant
time-reduction to the phage display process. We anticipate that this
easily-fabricated, disposable device has the potential to impact areas
ranging from fundamental studies of protein, peptide, and molecular
interactions, to applications such as fully automated proteomic
screening.Proteomics is an emerging field involving the study of protein func-
tions, activities, and interactions.1,2 In the last several decades, auto-
mated genomics technologies have led to high-throughput, low cost,
and rapid DNA sequencing. By contrast, access to proteomic tools
has been more restrictive due to their scale and expense.3Automated
robotic technologies have revolutionized biological research by
allowing much faster processing of large analytical assays,4 although
such systems are often limited in portability and require minimum
working volumes.5,6 By contrast, microfluidic systems allow for
reduced sample sizes, thereby rendering chemical and biological
assays more efficient and portable.7 An impressive variety of bio-
logical technologies has been incorporated into microfluidic chips,aDepartment of Chemical and Biological Engineering, Princeton
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562 | Lab Chip, 2012, 12, 562–565including protein crystallization,8 polymerase chain reaction (PCR),9
and enzyme-linked immunosorbent assays (ELISA).10 Such chips
have been designed with cell culture,11 antibody,12 genetic,13 and drug
delivery14 studies in mind. However, relatively few automated lab-on-
a-chip technologies have been developed for proteomic screening.15–17
Phage display is a powerful method for target-specific determina-
tion of molecular interactions, via the exploitation of discriminative
affinity selection. Further, its versatility has allowed studies of peptide
binding interactions against substrates as varied as metals,18
minerals,19,20 small molecules,21,22 polymers,23 and nanomaterials.24,25
In the phage display protocol, a direct phenotype-genotype linkage
provides for combinatorial screening of binding affinities toward
specified targets via an in vitro selection process termed biopanning.
For conventional selection processes, a target molecule is immobi-
lized onto a substrate, and subsequently incubated with a library of
phage-displayed peptides. Non-binding phage are washed away with
buffer while binding phage are collected using an acid elution step.
This is then followed by bacterial titer and amplification, and at least
two additional rounds of selection. After the final round of biopan-
ning, eluted phage are grown on agar plates, and individual plaques
are selected for DNA characterization to determine the amino acid
sequence of the phage-displayed peptides. While sufficient for
studying a single target, this process becomes time-consuming, labour
intensive and cumbersome with multiple target molecules. Although
recent studies on biopanning in large-scale fluidic devices have been
shown, they do not address the more time intensive components of
the process and thus are not any more amenable to high-throughput
multiplexing.26,27 Here we report for the first time a time-efficient
microfluidic approach that allows for simultaneous single-round
identification of binding sequences for multiple targets, without any
need for bacterial culture.
A device made entirely of silicone (polydimethylsiloxane, PDMS)
simplifies fabrication, while rendering the completed chip flexible,
portable, and disposable. A schematic of the functional components
of the device is outlined in Fig. 1. Consisting of three PDMS layers
(Fig. 1a), the phage display target is immobilized on the base layer
using established silicone surface chemistry modification techniques
(Fig. 1b).28,29 The middle tier contains channels through which
reagents flow, and is capped on top with channels which function as
valves and pumps controlling fluid flow.When pressurized gas enters
the control channels, the thin polymer membrane between the upper
two layers deflects downwards to obstruct further flow in the middle
layer (Fig. 1c). Once the pressure is lifted, the membrane rapidlyThis journal is ª The Royal Society of Chemistry 2012
Fig. 1 Elastomeric, multiplexed phage screening device. (a–c) Sche-
matics of (a) the trilayer device, with Control, Flow, and Target layers
labelled accordingly, (b) Target channel functionalization, and (c) Valve-
driven biopanning. (d) Photograph of completed device, with green and
red food dye representing flow and control channels, respectively.
Fig. 2 Simplified design of the multiplexed device, illustrating inlets and
outlets. Flow layer is shown in green, control layer in red.
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View Onlinereturns to its original position and fluid may commence circulation.
Unlike other microvalves, this design allows for rapid response time,
minimal leakage, and ease of fabrication.30 Small actuation forces
produce large membrane deflections, and complete sealing of chan-
nels is readily attained.
Indeed, these membrane deflections allow for efficient biopanning.
When control channels are serially arranged and pressure is cyclically
applied and released, a peristaltic pump is formed, wherein the flow
rate is controlled by the actuation frequency. Previous studies have
shown that similarly designed pumps can accelerate kinetics by at
least 60 times.31,32 Here, the peristaltic pump is used to agitate solu-
tions in the flow channel, mimicking the mixing and shakingmotions
employed during bulk phage display panning. Finally, the design
contains an inlet into which samples and buffers are introduced, an
outlet from which desired phage are collected, and a waste reservoir.
A photograph of a completed flexible device is shown in Fig. 1d.
Fabrication of the device follows standard lithographic protocols
for the flow and control layers. Positive photoresist, SPR 220-7
(Shipley Corp., Philadelphia, PA) was spin-coated to a height of 15
mm for the flow layer before being heated to 120 C to allow the
photoresist to reflow and form the rounded shape necessary for
complete channel closure. Negative photoresist, SU-8 2015 (Micro-
chem Corp., Newton, MA) was spin coated to a height of 25 mm for
the control layer. Room-temperature vulcanized PDMS (GE Sili-
cones, Waterford, NY) was used to create elastomeric replicas. A
20 : 1 (PDMS:crosslinker) mixture was used for the flow layer and
a 5 : 1 mixture was used for the control layer. The flow layer mixture
was spin-coated to produce a 30 mm thin elastomeric layer while the
control layer mixture was poured to a height of 2 mm. Both layers
were baked separately at 80 C for partial curing before the control
layer was removed from its master and perforated to create inlets for
the pressure source. This top layer was alignedwith the flow layer and
the two were cured together for an additional 30 min. The two-layer
assembly was then removed from the flow master and perforated to
create injection ports in the fluid layer. Lastly, this was brought into
contact with a flat slab of PDMS to complete the tri-layer device. The
chip was interfaced with a nitrogen gas pressure source via solenoidThis journal is ª The Royal Society of Chemistry 2012microvalves (Parker Hannifin Corp, Hollis, NH) and Tygon tubing
(Cole-Parmer, Vernon Hills, IL), and on-off sequences of valves and
pumps were governed by a programmable function generator. Flow
channels were 100 mmwide, 10 mm tall, and had an overall volume of
about 0.1 mL.
To test device functionality, a control target and three lesser-
studied targets were simultaneously screened. Streptavidin was
chosen as the robust control, as its consensus sequence – the HPQ
motif – has been well-established by existing phage display studies.33
The other targets chosen were tumor necrosis factor alpha (TNF-a),
interleukin-4 (IL-4), and interleukin-5 (IL-5), all of which are
important biomarkers in the pathology of asthma,34,35 and for which
consensus sequences have not been firmly established. Channel
design was streamlined such that multiple valves and pumps were
controlled by a single switch, according to the streamlined CAD
design shown in Fig. 2. Reagents common to all four targets,
including water, lysine, PBS, BSA, TBST, and the library itself,
stemmed from the same inlet, but each target had distinct waste
reservoirs and outlets to prevent cross-contamination.
Microscreening proceeded as follows. First, a surface modification
was applied to the entire device, according to the reactions in Scheme
1. Specifically, the channels were flushed with water, incubated with
0.01% p-L-lysine, and rinsed with buffer. After a subsequent incu-
bation of 12.5% glutaraldehyde, targets were introduced and allowed
to sit for 1 h at room temperature. This was followed by incubation of
40 mM ethanolamine solution and another buffer rinse.28 Next, the
device was coated with 5 mg mL1 BSA to prevent nonspecific
binding prior to introducing the phage library. Phages were agitated
in the channels for 1 h using the peristaltic pump before nonbinding
virions were flushed into their respective waste reservoirs using Tris-
buffered saline and 0.5% Tween-20.
Critically, a key departure from the conventional phage display
protocol was employed at this point in order to significantly reduce
overall time of the device operation. Rather than elute target-binding
phage with acid, a lysis buffer (10 mM Tris-HCl, pH 8.0, 100 mM
EDTA, 1% SDS) was introduced to release DNA from within the
remaining target-bound virions. The DNA-containing solution for
each of the separate targets was collected from the microfluidic
device and added to a PCR amplification mixture of REDTaq
polymerase (Sigma Aldrich, St. Louis, MO), forward primer
(50-CCTCGAAAGCAAGCTGATAAC-30), and reverse primer
(50-GTACCGTAACACTGAGTTTCG-30).36 The mixture was
placed in a thermocycler and subjected to 25 cycles of denaturation at
95 C for 30 s, annealing at 50 C for 30 s, extension at 72 C for 30 s,
and a final extension at 72 C for 5 min. Each of the four PCRLab Chip, 2012, 12, 562–565 | 563
Scheme 1 Surface modification of PDMS for target immobilization.
Table 1 Peptide sequences identified from the single-round, PCR-
amplified microfluidic chip
Target Sequence
Streptavidin NPWDEFRTHHPQ
TNF-a NNNKPNPHELHR
IL-4 NNDHARHLNYHS
IL-5 YMGMTKHNIYAQ
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View Onlineproducts was separated via electrophoresis on a 1.2% agarose gel,
with a single 0.33kb DNA amplimer confirming presence of phage
DNA. Gel extraction was performed and purified DNA for each
sample was characterized via automated sequencing methods.
Results of these single-round, multiplexed microfluidic panning
experiments are shown in Table 1. For streptavidin, the phage-dis-
played peptide contained the HPQ motif at the C-terminal position,
typical for the type of phage library used,27 thereby validating our
experimental approach. This result is significant because it demon-
strates that multiple rounds of biopanning and bacterial culture may
not be necessary to identify a specific binding peptide in the micro-
fluidic system. In parallel, sequences of the binders for TNF-a, IL-4,
and IL-5 were found, as shown in Table 1.
An earlier study had shown that lysing target-bound phage, rather
than eluting them, can result in the identification of unique sequences
overlooked by conventional biopanning.36 This is due to the fact that
high-affinity phage-displayed peptides are often left behind even after
extended acid elution, and can be further diluted by faster amplifying
phage during successive rounds of bacterial amplification and selec-
tion. Our results extend upon this study by eliminating not only the
need for bacterial amplification, but also the need to clone PCR
products into a vector and subsequently select individual clones forTable 2 Time of conventional and microfluidic phage display
Step Conventional Microfluidic
Microfluidic Fabrication — 4 h
Target Immobilization 1 h 3 h
Blocking 1 h 1 h
Wash 10 min 30 min
Biopanning 1 h 1 h
Wash 10 min 1 h27
Elution 1 h —
Lysing — 1 h
Bacterial Amplification & Phage Titer 16 h —
2nd, 3rd Rounds Biopanning 20 h  2 —
Purification for Sequencing 3 h —
PCR Amplification — 4 h
Total Time 63 h 16 h
Total Time per 4 Targets 63 h 4 h
564 | Lab Chip, 2012, 12, 562–565sequencing. In lieu of these steps, our optimized microfluidic panning
approach, followed by PCR amplification allows for the direct
detection of a single phage particle. In other words, not only does the
microfluidic process obviate bacterial titers and amplification, but it
also renders sequencing of individual phage clones unnecessary.
These simplifications dramatically reduce the overall time and labour
intensity of the phage display protocol, as outlined in Table 2.
Overall, this results in a ca. four-fold time reduction overall per target,
as compared to conventional phage display – a result that becomes
more significant with each additional target added. Indeed, for 4
targets, this results in a net 15-fold reduced time investment per target
relative to conventional phage display screening.Conclusions
We have created a microfluidic chip capable of identifying high
affinity phage-displayed peptides for multiple targets in just a single
round, without the need for any bacterial culture. The performance of
the device was confirmed via a control streptavidin target, while
simultaneously screening for three additional important biomarkers.
Not only does the device result in a significant fifteen-fold time
reduction and a ten-fold volume reduction per target, it is also more
sensitive – picking up sequences otherwise lost during conventional
phage display. Given that phage display is inherently a high
throughput assay, we anticipate that such a device would be
a powerful tool in molecular binding studies. Further, the disposable
nature of the device eliminates any possibility of cross-contamination.
The versatility of the target layer chemistry suggests that the device
can be similarly used to rapidly screen against other biomarkers,37
and a host of other materials, including metals,38 viruses,39 bacteria,40
and polymers.41 Indeed, this development has important implications
for many fields, including synthesis of protein nanomaterials, where
sequence and arrangement of peptides can be used to optimize the
activity of nanotubes,42 nanoparticles,43 and other nanostructures.44
In future studies, we plan on 1) extending the multiplexed design to
wafer-scale arrays, allowing for more targets in parallel assays, 2)
further automating the process with software and controls, and 3)
incorporating the PCR step directly into the device via microfluidic
PCRmodules.45While we were able to pinpoint single target-binding
peptide sequences in this study, it is possible that other targets may
have more than one binding sequence associated with them. Conse-
quently, next generationDNA sequencing can be used to characterize
cohorts of phage clones.
We thank Andrew Hsu for valuable discussions and illustrations.
This research was supported by the Air Force Office of Scientific
Research (AFOSR) (#FA9550-09-1-0096) and by the American
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